Earnings History Data for Puma Biotechnology Inc (PBYI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Puma Biotechnology Inc

Puma Biotechnology, Inc. is a biopharmaceutical company focused on the acquisition, in-licensing, development and commercialization of novel therapeutics for the treatment of cancer. Its products under development include PB272 (oral neratinib) for the treatment of patients with human epidermal growth factor receptor type 2 (HER2) positive metastatic breast cancer and gastric cancer and PB272 (neratinib intravenous) for the treatment of patients with advanced cancer. Puma Biotechnology, Inc. is headquartered in Los Angeles, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-08-2023	AH		PBYI	Puma Biotechnology Inc	165.81	0.05	0.01	0.21	Puma Biotechnology Non-GAAP EPS of $0.05 misses by $0.02, revenue of $54.6M beats by $2.87M [8/3/2023 4:51 PM]	3.82	0.30 (8.52%)	3.56	0.04 (1.14%)	2.08 - 5.16	584,443	110,000	225
Puma Biotechnology Non-GAAP EPS of $0.05 misses by $0.02, revenue of $54.6M beats by $2.87M [8/3/2023 4:51 PM]
04-05-2023	AH	4:05 PM ET (May 4)	PBYI	Puma Biotechnology Inc	123.60	0.03	-0.10	-0.08	Puma Biotechnology Non-GAAP EPS of $0.09, revenue of $52.8M [5/4/2023 4:48 PM]	3.17	0.56 (21.26%)	2.90	0.29 (11.11%)	1.60 - 5.16	706,988	120,000	7,103
Puma Biotechnology Non-GAAP EPS of $0.09, revenue of $52.8M [5/4/2023 4:48 PM]
02-03-2023	AH	4:05 PM ET (Mar 2)	PBYI	Puma Biotechnology Inc	188.63	-0.12	0.06	0.10	Puma Biotechnology reports Q4 results, provides Q1, FY 2023 guidance [3/2/2023 4:14 PM]	3.19	-0.79 (-19.85%)	3.70	-0.28 (-7.04%)	1.60 - 5.16	1,169,191	220,000	2,335
Puma Biotechnology reports Q4 results, provides Q1, FY 2023 guidance [3/2/2023 4:14 PM] Puma stock slumps ~15% as Q4 sees loss on lawsuit settlement; impact on Nerlynx sales in Q1 [3/3/2023 11:31 AM]
03-11-2022	AH	4:05 PM ET (Nov 3)	PBYI	Puma Biotechnology Inc	102.50	-0.01	-0.11	-1.09	Puma Biotechnology Non-GAAP EPS of $0.05, revenue of $57.1M [11/3/2022 4:28 PM]	2.68	0.54 (25.23%)	2.45	0.31 (14.49%)	1.60 - 6.76	468,575	110,000	182
Puma Biotechnology Non-GAAP EPS of $0.05, revenue of $57.1M [11/3/2022 4:28 PM] Puma soars 17% as breast cancer drug Nerlynx drives Q3 sales, raises outlook [11/4/2022 12:09 PM] Puma Biotech (PBYI) Reports Q3 Loss, Tops Revenue Estimates [Nov-03-22 06:45PM] Puma Biotechnology Reports Third Quarter 2022 Financial Results [Nov-03-22 04:05PM]
04-08-2022	AH	4:05 PM ET (Aug 4)	PBYI	Puma Biotechnology Inc	144.81	0.21	0.02	-0.13	Puma Biotechnology Non-GAAP EPS of $0.28, revenue of $59.5M [8/4/2022 4:44 PM]	3.84	0.57 (17.43%)	3.84	0.0 (0.00%)	1.60 - 7.84	669,041	180,000	2,516
Puma Biotechnology Non-GAAP EPS of $0.28, revenue of $59.5M [8/4/2022 4:44 PM] Puma Biotechnology Reports Second Quarter 2022 Financial Results [Aug-04-22 04:05PM]
05-05-2022	AH	4:05 PM ET (May 5)	PBYI	Puma Biotechnology Inc	103.83	-0.08	-0.13	0.40	Puma Biotechnology Non-GAAP EPS of -$0.01 beats by $0.10, revenue of $45.7M beats by $0.63M [5/5/2022 4:42 PM]	1.99	-0.25 (-11.38%)	2.40	0.16 (7.14%)	1.98 - 11.95	426,778	340,000	6,174
Puma Biotechnology Non-GAAP EPS of -$0.01 beats by $0.10, revenue of $45.7M beats by $0.63M [5/5/2022 4:42 PM] Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue Estimates [May-04-22 05:35PM] Puma Biotechnology Reports First Quarter 2022 Financial Results [May-05-22 04:05PM] Puma Biotech (PBYI) Reports Q1 Loss, Misses Revenue Estimates [May-05-22 06:05PM] Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Fall Y/Y [May-06-22 11:01AM]
03-03-2022	AH	4:05 PM ET (Mar 3)	PBYI	Puma Biotechnology Inc	94.04	0.10	-0.10	-0.38	Puma Biotechnology Non-GAAP EPS of $0.21 beats by $0.20, revenue of $55.4M beats by $8.23M [3/3/2022 4:11 PM]	2.56	0.23 (9.87%)	2.44	0.11 (4.72%)	2.06 - 11.95	1,914,647	340,000	122,500
Puma Biotechnology Non-GAAP EPS of $0.21 beats by $0.20, revenue of $55.4M beats by $8.23M [3/3/2022 4:11 PM] Puma Biotechnology up 15% after quarterly earnings beats [3/3/2022 5:27 PM] Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results [Mar-03-22 04:05PM] Puma Biotech (PBYI) Q4 Earnings and Revenues Surpass Estimates [Mar-03-22 06:05PM] Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) [Mar-04-22 05:00PM]
04-11-2021	AH	4:05 PM ET (Nov 4)	PBYI	Puma Biotechnology Inc	232.85	-1.09	-0.23	-0.79	Puma Biotechnology EPS misses by $0.77, misses on revenue [11/4/2021 4:33 PM]	3.99	-2.40 (-37.56%)	5.00	-1.39 (-21.75%)	3.99 - 14.14	4,067,428	600,000	199,760
Puma Biotechnology EPS misses by $0.77, misses on revenue [11/4/2021 4:33 PM] Puma Biotechnology extends losses on earnings miss [11/5/2021 6:50 AM] Puma Biotechnology Reports Third Quarter 2021 Financial Results [Nov-04-21 04:07PM] Puma Biotech (PBYI) Reports Q3 Loss, Misses Revenue Estimates [Nov-04-21 06:45PM] Puma (PBYI) Misses on Q3 Earnings, Cuts Sales View, Stock Down [Nov-05-21 10:31AM]
05-08-2021	AH	4:05 PM ET (Aug 5)	PBYI	Puma Biotechnology Inc	295.05	-0.13	-0.31	0.08	Puma Biotechnology EPS beats by $0.46, beats on revenue [8/5/2021 4:24 PM]	7.11	0.12 (1.69%)	7.18	0.19 (2.72%)	6.48 - 14.14	1,526,458	390,000	20,926
Puma Biotechnology Reports Second Quarter 2021 Financial Results [Aug-05-21 04:07PM] Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates [Aug-05-21 08:25PM] Puma (PBYI) Q2 Loss Narrower Than Expected, Nerlynx View Cut [Aug-06-21 12:27PM] Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) [Aug-06-21 04:50PM]
06-05-2021	AH	4:05 PM ET (May 6)	PBYI	Puma Biotechnology Inc	395.95	0.40	0.29	-0.43	Puma Biotechnology EPS beats by $0.21, beats on revenue [5/6/2021 4:42 PM]	9.79	0.11 (1.14%)	9.79	0.0 (0.00%)	7.48 - 14.14	359,152	240,000	10,076
Puma Biotechnology EPS beats by $0.21, beats on revenue [5/6/2021 4:42 PM] Puma Biotechnology, Inc. to Host Earnings Call [May-06-21 02:45PM] Puma Biotechnology Reports First Quarter 2021 Financial Results [May-06-21 04:05PM] Puma Biotech (PBYI) Q1 Earnings and Revenues Beat Estimates [May-06-21 07:05PM] Puma (PBYI) Beats on Q1 Earnings, Ups Nerlynx Sales View [May-07-21 08:52AM]
25-02-2021	AH	4:05 PM ET (Feb 25)	PBYI	Puma Biotechnology Inc	433.01	-0.38	-0.18	-0.29	Puma Biotechnology EPS misses by $0.05, misses on revenue [2/25/2021 4:14 PM]	9.97	-0.58 (-5.50%)	10.55	0.0 (0.00%)	5.50 - 14.14	348,905	356,123	2,169
Puma Biotechnology EPS misses by $0.05, misses on revenue [2/25/2021 4:14 PM] Puma Biotechnology and Pierre Fabre amend NERLYNX license agreement [2/25/2021 4:12 PM] Puma Biotechnology and CANbridge terminate NERLYNX license agreement [2/26/2021 8:49 AM] Puma (PBYI) Q4 Loss Wider Than Expected, Nerlynx Sales Fall [Feb-26-21 10:10AM] The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida [Feb-26-21 08:16AM] Puma Biotechnology and Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China [Feb-25-21 04:07PM]
05-11-2020	AH	4:05 PM ET (Nov 5)	PBYI	Puma Biotechnology Inc	314.64	-0.79	-0.33	-0.44	Puma Biotechnology EPS misses by $0.46, misses on revenue [11/5/2020 4:42 PM]	7.76	-0.71 (-8.38%)	8.01	-0.46 (-5.43%)	5.50 - 15.00	1,087,805	512,740	4,951

06-08-2020	AH	4:05 PM ET (Aug 6)	PBYI	Puma Biotechnology Inc	428.68	0.08	-0.26	-0.97	Puma Biotechnology EPS beats by $0.20, beats on revenue [8/6/2020 4:09 PM]	9.99	-0.39 (-3.76%)	10.40	0.02 (0.19%)	5.50 - 15.00	1,712,839	1,032,804	4,790